Hormonal · GHRH · GH/IGF-1 axis

TesaFit+Tesamorelin

GHRH analog (FDA) · visceral fat

The ReferenceBenefits, protocols and preparationOpen the reference →
Purity
≥99%
Format
20mg
Class
GHRH
Axis
GH/IGF-1
Molecule approved in United States and Canada · 2010What this means ›
🇺🇸 United States · Approved🇨🇦 Canada · Approved

The molecule is approved as a medicine in United States and Canada, under the brand Egrifta. Approved to reduce abdominal visceral fat in HIV-associated lipodystrophy (FDA, 2010; the Egrifta WR presentation since March 2025; Health Canada under the same brand). It is the only growth-hormone-axis compound with approval.

What is approved is the molecule under that pharmaceutical brand. Our vial is research material (RUO).

Source: FDA · Egrifta (2010), Egrifta WR (mar 2025) · Health Canada · Egrifta

For research use only (RUO) Ships from Quito · EC 1-3 days · LATAM 4-10 Arrives damaged? We replace it free COA per batch
CAS · 218949-48-5 MW · 5135.9 Da Stock · Available
How it works

4 mechanisms. Physiological GH axis.

Tesamorelin is a stabilized GHRH analog (44 aa) — the only growth hormone secretagogue approved by the FDA (Egrifta). It stimulates your own GH in a pulsatile way, preserving natural IGF-1 feedback.

Visceral fat ↓

Its FDA-approved flagship use: reduces visceral abdominal fat (−15 to −18% in trials) — the fat that wraps around your organs.

Physiological GH/IGF-1

Raises GH and IGF-1 pulsatilely, not flat. Preserves IGF-1 feedback, unlike exogenous growth hormone.

Liver and composition

−37% liver fat in 12 months (Lancet HIV 2019) and a modest lean-mass gain.

Cognition

Better executive function in 152 older adults after 20 weeks (Arch Neurol 2012).

Why combine it

More muscle, strength & composition

See all combinations in the Consultation →
The compound

Technical description.

Tesamorelin is a stabilized synthetic analog of GHRH (growth hormone–releasing hormone, 44 amino acids) and is the only GHRH analog FDA-approved as a treatment (brand Egrifta; its WR version in 2025). Instead of injecting growth hormone directly, it asks your own pituitary to release it — pulsatilely and preserving natural IGF-1 feedback.

SuperBio Labs Tesamorelin is supplied as lyophilized powder with verified HPLC ≥99% purity. Each lot ships with an independent Certificate of Analysis confirming identity by LC-MS, peptide content (98–102%), and endotoxin levels (<1.0 EU/mg).

Its flagship lane, with high evidence, is reducing visceral abdominal fat: −15 to −18% in 26 weeks across two phase III trials with 806 people. A 2026 meta-analysis confirms it and adds less trunk fat and lower triglycerides. In fatty liver it cut liver fat by 37% over 12 months and slowed fibrosis progression (Lancet HIV 2019; confirmed in 2024). In older adults it improved executive function after 20 weeks (Arch Neurol 2012). The lean-mass gain is modest: this is not a muscle-building peptide. Two honest notes: most evidence comes from people with HIV and older adults, and visceral fat returns within a few months of stopping.

Within our catalog, Tesamorelin holds the GH-axis slot: it gains credibility (FDA) and a lane of its own (visceral fat), but it does not build muscle nor provide the ghrelin/sleep arm of an Ipamorelin.

Informed professional research use only.

Complete kit · ready to reconstitute.

Each order includes everything needed to use the full vial. No separate purchases required.

Vial + BWFI + syringes + alcohol swabs · kit contents
1× lyophilized Tesamorelin 20mg vial
1× 3 ml BWFI vial (bacteriostatic water)
insulin syringes U-100 0.5ml 29G
alcohol wipes 70%
1× cycle organizer box
1× printed reconstitution guide
1× nighttime application protocol
1× batch COA (digital + printed)
Before you buy · from any store

How to choose where to buy peptides.

01
Per-batch, verifiable COA The certificate exists and can be checked — not "available on request".
→
02
HPLC purity + LC-MS identity How much is in the vial, and that it is the right peptide.
→
03
Endotoxins tested LAL test within range — not just purity.
→
04
2-8°C cold chain Documented end to end, not promised.
→
05
Traceability and support Lot number on the vial and someone who answers after.

This product meets all five — your batch COA ships with the kit.

Recommended application protocol.

The official protocol included in the kit. If you have pre-diabetes, diabetes, or raised IGF-1, consult your physician before starting.

Reconstitution
2 ml of bacteriostatic water → 10 mg/ml
Standard dose
1 mg
U-100 units
10 u
Frequency
5-on / 2-off
Best timing
Night, fasted (respects the nocturnal GH pulse)
Cycle length
12 weeks ON / 4 weeks OFF
Combine with
Tirz, MOTS-c · never with CJC-1295 (dual GHRH)
Storage (reconstituted)
60 days refrigerated (2–8°C)

When to use Tesamorelin.

Visceral fat

The fat around your organs · −15 to −18% in 26 weeks in phase III.

Fatty liver

−37% liver fat in 12 months (HIV) · no published results outside HIV yet.

GH/IGF-1 axis

Raises GH and IGF-1 with your own pulses, no exogenous GH · monitor with labs.

Cognition with age

Better executive function after 20 weeks in 152 older adults.

High triglycerides

Triglycerides fell along with visceral fat in phase III.

Consistency

When stopped, visceral fat returns within months · the effect lasts while you keep going.

Honest side effects.

Generally well tolerated, but with clear monitoring. This is not a harmless peptide: it has real contraindications.

It raises IGF-1 (monitor with labs) and can raise glucose/insulin — caution in pre-diabetes and diabetes. It may cause fluid retention and arthralgia (joint pain). Contraindicated in active cancer, pituitary disease, and pregnancy. For athletes: it is on the WADA list (S2.2.4). Never combine it with CJC-1295 (both are GHRH).

Technical specifications

CAS number218949-48-5
Molecular weight5135.9 Da
ClassGHRH analog (44 aa)
Purity (HPLC)≥99%
FormatLyophilized powder
Quantity20 mg per vial
Endotoxins<1.0 EU/mg
Storage−20 °C, protected from light
UseUse under professional judgment

Also in Hormonal and recovery